Sodium ‐glucose cotransporter 2 inhibitor effects on heart failure hospitalization and cardiac function: systematic review

ConclusionsSodium –glucose cotransporter 2 inhibitors reduce HHF regardless of T2DM status, and reversal of adverse left ventricular remodelling likely contributes to this efficacy. Hypothesis-driven mechanistic trials remain sparse, although numerous trials are planned or ongoing.

Source: ESC Heart Failure - July 5, 2021 Category: Cardiology Authors: Roy Rasalam, John J. Atherton, Gary Deed, Michael Molloy ‐Bland, Neale Cohen, Andrew Sindone Tags: Original Research Article Source Type: research